Correction: Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells

Oncotarget. 2020 Jan 21;11(3):300-301. doi: 10.18632/oncotarget.27373.

¹ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China.
² Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu Province, People's Republic of China.
³ Department of Chemistry and Biochemistry, Florida International University, Miami, FL, USA.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.2340.].